Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine
Abstract
Adenocarcinoma of the small intestine (ACSI) is a rare condition with few studies addressing follow-up and prognosis. Tumors of 35 patients with curative resection of an ACSI were retrospectively analyzed by immunohistochemistry: p53, hMLH1, hMSH2 and hMSH6 and microsatellite instability (MSI): BAT-26, BAX, TGF-β RII. With a median follow up of 6.1 years, the median cancer-specific survival (CSS) was 36.2 months. Patients who were highly instable (MSI-H) (n=10) had a CSS of 49.6 months in contrast to patients with stable tumors (23.2 months) (P=0.010). Additionally, a low tumor stage according to UICC and MSI-H were shown to be independent factors (P=0.005 and P<0.001) for an increased survival in multivariate analysis. Therefore, it is suggested that analysis of the MSI status might prove useful in discerning prognosis within cancers of the same stage.
Keywords: Adenocarcinoma of the small intestine, Microsatellite instability, Mismatch repair deficiency, Prognosis
Abbreviations: ACSI, adenocarcinoma of the small intestine, FAP, familial adenomatous polyposis, HNPCC, hereditary non-polyposis colon cancer, MMR, mismatch repair, MSI, microsatellite instability, mut, mutation, wt, wild type
To access this article, please choose from the options below
PII: S0304-3835(03)00573-1
doi:10.1016/j.canlet.2003.08.013
© 2003 Elsevier Ireland Ltd. All rights reserved.
